DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Avodart (Dutasteride) - Current Clinical Trials

 
 



Avodart Related Clinical Trials

Study Assessing The Efficacy And Safety Of Avodart (Dutasteride) At Improving Urinary Symptoms In Men With Prostate Cancer Who Are Undergoing Seed Implantation [Completed]

Bioequivalence - Duodart Against Avodart & Omnic [Completed]

Bioavailability of Two Combination Products of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) in Asian Males. [Completed]

AVODART« Alopecia Post-marketing Surveillance (PMS) [Completed]

Dutasteride After Failure of Finasteride In the Management of Symptomatic Prostatic Enlargement/Hypertrophy (BPE/H) [Completed]

AVODART(Dutasteride) Post-marketing Surveillance(PMS) [Completed]

Dutasteride for the Reduction of Alcohol Use in Male Drinkers [Completed]

Pharmacokinetic Study of Single Dose Dutasteride in Healthy Subjects [Completed]

Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride [Completed]

Dutasteride Versus Placebo and Finasteride in Men With Androgenetic Alopecia [Completed]

A Study To Compare Giving AVODART And FLOMAX Together Or In A Combination Capsule In The Fed And Fasted State [Completed]

MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate Cancer [Completed]

Safety and Pharmacokinetic Characteristics of DKF-313 [Recruiting]

TRADE-Testosterone Replacement and Dutasteride Effectiveness [Completed]

Oral Androgens in Man-4: (Short Title: Oral T-4) [Completed]

A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia [Completed]

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin HCl Combination Capsule in Fed State [Completed]

Bioequivalence Study of the Second Generation Dutasteride and Tamsulosin Hydrochloride (HCL) Combination Capsule in Fasted State [Completed]

Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Men [Completed]

Dutasteride to Treat Spinal and Bulbar Muscular Atrophy (SBMA) [Completed]

Dutasteride 0.5mg For The Treatment Of Chinese Patients With Benign Prostatic Hyperplasia (BPH) [Completed]

A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia [Completed]

Response of Patients on Surveillance for Prostate Cancer to Dutasteride [Completed]

Bioavailability Study of Fixed Dose Combination (FDC) Dutasteride and Tamsulosin Hydrochloride (HCl) Relative to One Dutasteride and One Tamsulosin HCl Tablet in Healthy Male Subjects [Not yet recruiting]

This Will be an Open-label, Three-period, Fixed-sequence Study to Evaluate the Drug-drug Interaction, Pharmacokinetics and Safety of Dutasteride and Tamsulosin When Administered Alone and In-combination in Chinese Healthy Male Volunteers. The Study Will Last Approximately Eleven Weeks. Blood Samples [Completed]

A Study to Determine the Bioavailability of a Fixed Dose Combination Product of Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) Relative to Co-administration of the Individual Components in Healthy Male Subjects of North East Asian and Non-Asian Ancestry. [Completed]

Efficacy and Toxicity of Bicalutamide and Dutasteride vs. Standard Care for Prostate Cytoreduction for Brachytherapy [Active, not recruiting]

28-Day Study of Testosterone Co-administered With Dutasteride in Hypogonadal Men [Completed]

Bioequivalence Study of Dutasteride Five 0.1 mg and One 0.5 mg Soft Gelatin Capsules in Healthy Male Volunteers [Completed]

Ketoconazole, Hydrocortisone and Dutasteride in Asymptomatic Hormone Refractory Prostate Cancer [Completed]

Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer [Completed]

Efficacy Study for Use of Dutasteride (Avodart) With Testosterone Replacement [Completed]

Extension Study of GI198745 to Treat Benign Prostatic Hyperplasia [Completed]

Dutasteride Treatment for the Reduction of Heavy Drinking in Men [Recruiting]

Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer [Completed]

Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer [Active, not recruiting]

Pharmacogenetics of Alcohol: Treatment Implications [Completed]

STA-9090 in Castration-Resistant Prostate Cancer With Assessment of Androgen Receptor Pathway Signaling [Withdrawn]

Effect Of Dutasteride On Intraprostatic Dihydrotestosterone (DHT) Levels [Completed]

A Long-term Study to Determine Safety and Efficacy of Dutasteride in Male Subjects With Androgenetic Alopecia [Completed]

ITT-5 Mechanisms of Spermatogenesis [Not yet recruiting]

Effect of Dutasteride on Bladder Wall Hypertrophy in Patients With Benign Prostatic Obstruction [Completed]

Dutasteride With Tolterodine ER or Placebo to Treat Lower Urinary Tract Symptoms (LUTS) [Completed]

Comparative Bioavailability of Two Fixed Dose Combination (FDC) Formulations of Dutasteride and Tamsulosin Hydrochloride Relative to Co-administration of Dutasteride With Tamsulosin Hydrochloride in Healthy Male Subjects Under Fed and Fasted States [Completed]

Study to Compare the Bioavailability of Dutasteride Novel Formulation Form to the Soft Gel Capsule Form in Healthy Male Subjects [Completed]

Safety and Efficacy of 0.5mg Dutasteride and 0.4mg Tamsulosin Combination Once Daily for Six Months for Benign Prostatic Hyperplasia [Terminated]

Comparing 0.5 mg Dutasteride vs Placebo Daily in Men Receiving Androgen Ablation Therapy for Prostate Cancer [Active, not recruiting]

A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy [Withdrawn]

Dutasteride Followed By Ultrasound-Guided Biopsy in Finding Prostate Cancer [Completed]

A Clinical Trial Comparing Laser TURP With and Without Dutasteride. [Terminated]

Study to Compare the Efficacy and Safety of Combination Treatment With Dutasteride and Tamsulosin With Tamsulosin Monotherapy, in Men With Moderate to Severe Benign Prostatic Hyperplasia [Active, not recruiting]

Pharmacovigilance Study To Evaluate Safety Of AVODART In Subjects With Benign Prostate Hyperplasia [Completed]

Dutasteride (GI198745) In Benign Prostatic Hyperplasia Subjects [Completed]

Effect of Dutasteride on HIF-1alpha and VEGF in the Prostate [Completed]

Benign Prostatic Hyperplasia Trial With Dutasteride And Tamsulosin Combination Treatment [Completed]

Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia [Completed]

ITT4 Intratesticular Hormonal Milieu in Man (ITT4) [Completed]

Comparative Efficacy of Dutasteride Plus Tamulosin With Lifestyle Advice Versus Watchful Waiting Plus Lifestyle Advice in the Management of Treatment naïve Men With Moderately Symptomatic Benign Prostatic Hyperplasia and Prostate Enlargement [Completed]

Ketoconazole, Hydrocortisone, Dutasteride and Lapatinib (KHAD-L) in Prostate Cancer [Active, not recruiting]

Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy [Completed]

Enzalutamide & Dutasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer. [Recruiting]

PROS-1-Male Hormonal Contraceptive Regimens on Prostate Tissue [Completed]

Long-term Effects of Dutasteride on Architectural and Nuclear Morphometric Features of Benign Prostate Tissue [Active, not recruiting]

Dutasteride to Treat Women With Menstrually Related Mood Disorders [Completed]

Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride [Completed]

Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its Progression [Recruiting]

Dutasteride in Treating Patients With Prostate Cancer [Recruiting]

Combination Statin, Acetylsalicylic Acid and Dutasteride Use in Prostate Cancer [Completed]

A Study to Determine the Improvement of the Symptoms of Benign Prostatic Hyperplasia (BPH) When Switching Subjects From Proscar to Avodart [Enrolling by invitation]

Metabolic Effects of Steroids in Obese Men [Active, not recruiting]

Dutasteride in Treating Patients With Recurrent Prostate Cancer That Did Not Respond to Androgen-Deprivation Therapy [Completed]

Dutasteride for Improving Peri-Operative and Long-Term Outcomes of Photoselective Vaporization of the Prostate (DOP) [Active, not recruiting]

Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer [Recruiting]

Study of Tamsulosin and/or Dutasteride to Relieve Urinary Symptoms After Brachytherapy for Localized Prostate Cancer [Completed]

Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter [Terminated]

Effects On Dihydrotestosterone Regulated Gene Expression In Benign Prostatic Hyperplasia Or Prostate Cancer [Completed]

A Study To Compare 3 Different Formulations Of Tamsulosin At Steady State. [Completed]

For Cause Prostate Biopsy in REDUCE Population Trial [Completed]

Drug Use Investigation for AVOLVE(BPH) [Completed]

Economic Analyses of the REDUCE Trial [Completed]

Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer [Active, not recruiting]

Testosterone and Its Metabolites in GID [Completed]

Dutasteride in Enlarged Prostate Economic Assessment: A Retrospective Database Pooled Analysis of Early 5-alpha Reductase Inhibitor Use [Completed]

Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker [Completed]

Prospective Sexual Function Study for BPH Subjects [Recruiting]

Clinical and Economic Outcomes of Patients Utilizing Combination Therapy for Enlarged Prostates: A Henry Ford Database Assessment [Completed]

Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer [Completed]

Clinical Progression and Costs in Benign Prostatic Hyperplasia Patients Treated With Early Versus Delayed Combination Therapy [Completed]

The Utility of PSADv (PSA Density Velocity) While on Dutasteride for Predicting Prostate Cancer Incidence and Grade and Stage [Not yet recruiting]

JALYN for Benign Prostatic Hyperplasia (BPH) and Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS) [Terminated]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017